Ligand validation:6DK0

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6DK0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6DK0_OLC_C_307	18%	62%	0.178	0.89	0.98	0.5	-	-	0	0	32%	0.32
6DK0_OLC_C_310	13%	63%	0.249	0.918	0.98	0.46	-	-	0	0	32%	0.32
6DK0_OLC_A_311	7%	64%	0.256	0.839	0.97	0.43	-	-	0	0	32%	0.32
6DK0_OLC_C_308	4%	49%	0.314	0.808	1.11	0.88	1	-	2	0	36%	0.36
6DK0_OLC_C_309	3%	49%	0.298	0.755	1.12	0.85	-	-	0	0	36%	0.36
6DK0_OLC_C_306	2%	64%	0.348	0.778	0.97	0.42	-	-	0	0	32%	0.32
6DK0_OLC_A_310	2%	47%	0.352	0.713	1.11	0.93	1	-	0	0	36%	0.36
6DK0_OLC_A_309	0%	65%	0.692	0.836	0.96	0.41	-	-	0	0	32%	0.32
6DJZ_OLC_C_310	36%	48%	0.111	0.917	1.12	0.89	1	-	0	0	36%	0.36
5HK1_OLC_A_309	17%	51%	0.21	0.876	0.94	0.97	1	1	0	0	52%	0.52
5HK2_OLC_B_309	12%	88%	0.253	0.919	0.33	0.33	-	-	0	0	28%	0.28
6DK1_OLC_C_312	12%	43%	0.276	0.894	1.12	1.09	2	1	1	0	52%	0.52
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.